Castle Biosciences (CSTL) Research & Development (2018 - 2025)
Castle Biosciences (CSTL) has disclosed Research & Development for 8 consecutive years, with $13.5 million as the latest value for Q4 2025.
- Quarterly Research & Development rose 14.8% to $13.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $51.8 million through Dec 2025, changed 0.37% year-over-year, with the annual reading at $51.8 million for FY2025, 0.37% changed from the prior year.
- Research & Development hit $13.5 million in Q4 2025 for Castle Biosciences, up from $13.0 million in the prior quarter.
- In the past five years, Research & Development ranged from a high of $14.4 million in Q1 2023 to a low of $5.9 million in Q1 2021.
- Historically, Research & Development has averaged $11.6 million across 5 years, with a median of $12.5 million in 2024.
- Biggest five-year swings in Research & Development: surged 151.22% in 2021 and later fell 9.54% in 2025.
- Year by year, Research & Development stood at $9.4 million in 2021, then grew by 19.74% to $11.3 million in 2022, then increased by 14.9% to $13.0 million in 2023, then decreased by 9.4% to $11.8 million in 2024, then grew by 14.8% to $13.5 million in 2025.
- Business Quant data shows Research & Development for CSTL at $13.5 million in Q4 2025, $13.0 million in Q3 2025, and $12.8 million in Q2 2025.